99
Views
0
CrossRef citations to date
0
Altmetric
Commentary

RNA Editors: Key Regulators of Viral Response in Cancer Patients

ORCID Icon & ORCID Icon
Pages 165-167 | Received 25 Oct 2020, Accepted 14 Jan 2021, Published online: 27 Jan 2021

References

  • Lee LYW , CazierJB , StarkeyTet al. COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study. Lancet Oncol.21(10), 1309–1316 (2020).
  • Paramasivam A , PriyadharsiniJV. Epigenetic modifications of RNA and their implications in antiviral immunity. Epigenomics12(19), 1673–1675 (2020).
  • Ramírez-Moya J , BakerAR , SlackFJet al. ADAR1-mediated RNA editing is a novel oncogenic process in thyroid cancer and regulates miR-200 activity. Oncogene39(18), 3738–3753 (2020).
  • Galante PA , SandhuD , deSousa Abreu Ret al. A comprehensive in silico expression analysis of RNA binding proteins in normal and tumor tissue: identification of potential players in tumor formation. RNA Biol.6(4), 426–433 (2009).
  • Kung CP , MaggiLBJr , WeberJD. The role of RNA editing in cancer development and metabolic disorders. Front. Endocrinol. (Lausanne)9, 76210.3389/fendo.2018.00762 (2018).
  • Samuel CE . ADARs: viruses and innate immunity. Curr. Top. Microbiol. Immunol.353, 163–19510.1007/82_2011_148 (2012).
  • Doria M , NeriF , GalloAet al. Editing of HIV-1 RNA by the double-stranded RNA deaminase ADAR1 stimulates viral infection. Nucleic Acids Res.37(17), 5848–5858 (2009).
  • Cachat A , AlaisS , ChevalierSAet al. ADAR1 enhances HTLV-1 and HTLV-2 replication through inhibition of PKR activity. Retrovirology11, 9310.1186/s12977-014-0093-9 (2014).
  • Zhou S , YangC , ZhaoFet al. Double-stranded RNA deaminase ADAR1 promotes the Zika virus replication by inhibiting the activation of protein kinase PKR. J. Biol. Chem.294(48), 18168–18180 (2019).
  • Liao GR , TsengYY , TsengCYet al. Adenosine deaminase acting on RNA 1 associates with Orf virus OV20.0 and enhances viral replication. J. Virol.93(7), e01912–e01918 (2019).
  • Doria M , TomaselliS , NeriFet al. ADAR2 editing enzyme is a novel human immunodeficiency virus-1 proviral factor. J. Gen. Virol.92(5), 1228–1232 (2011).
  • Di Giorgio S , MartignanoF , TorciaMGet al. Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2. Sci. Adv.6(25), eabb5813 (2020).
  • Swanton C , McGranahanN , StarrettGJ , HarrisRS. APOBEC enzymes: mutagenic fuel for cancer evolution and heterogeneity. Cancer Discov.5(7), 704–712 (2015).
  • Stavrou S , RossSR. APOBEC3 proteins in viral immunity. J. Immunol.195(10), 4565–4570 (2015).
  • Li S , BaoX , WangDet al. APOBEC3B and IL-6 form a positive feedback loop in hepatocellular carcinoma cells. Sci. China Life Sci.60(6), 617–626 (2017).
  • Matyášek R , KovaříkA. Mutation patterns of human SARS-CoV-2 and bat RaTG13 coronavirus genomes are strongly biased towards C >U transitions, indicating rapid evolution in their hosts. Genes (Basel)11(7), 761 (2020).
  • Kosuge M , Furusawa-NishiiE , ItoKet al. Point mutation bias in SARS-CoV-2 variants results in increased ability to stimulate inflammatory responses. Sci. Rep.10(1), 17766 (2020).
  • Xia X . Extreme genomic CpG deficiency in SARS-CoV-2 and evasion of host antiviral defense. Mol. Biol. Evol.37(9), 2699–2705 (2020).
  • Zhang T , CaiJ , ChangJet al. Evidence of associations of APOBEC3B gene deletion with susceptibility to persistent HBV infection and hepatocellular carcinoma. Hum. Mol. Genet.22(6), 1262–1269 (2013).
  • Singh KK , WangY , GrayKPet al. Genetic variants in the host restriction factor APOBEC3G are associated with HIV-1-related disease progression and central nervous system impairment in children. J. Acquir. Immune Defic. Syndr.62(2), 197–203 (2013).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.